Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001823239-25-000063
Filing Date
2025-05-12
Accepted
2025-05-12 16:28:37
Documents
83
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrvi-20250331.htm   iXBRL 10-Q 1229570
2 EX-31.1 mrvi-q12025form10xqxex311x.htm EX-31.1 8883
3 EX-31.2 mrvi-q12025form10xqxex312x.htm EX-31.2 8814
4 EX-32.1 mrvi-q12025xform10xqxex321.htm EX-32.1 4773
5 EX-32.2 mrvi-q12025xform10xqxex322.htm EX-32.2 4714
  Complete submission text file 0001823239-25-000063.txt   7418280

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20250331.xsd EX-101.SCH 49071
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrvi-20250331_cal.xml EX-101.CAL 89408
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrvi-20250331_def.xml EX-101.DEF 308802
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20250331_lab.xml EX-101.LAB 640305
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20250331_pre.xml EX-101.PRE 492754
85 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20250331_htm.xml XML 948486
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39725 | Film No.: 25935277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)